KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells

Killer cell immunoglobulin‐like receptor/HLA class I (KIR/HLA‐I) combinations are associated with disease risk, implicating functional roles for NK cells (NKCs) or KIR+ T cells. KIR/HLA‐I interactions can act through inhibition of NKC activation by target cells and NKC licensing for greater intrinsic responsiveness. We compared licensing conferred by the weaker, HLA‐C group 1/KIR2DL3, and the stronger, HLA‐C group 2/KIR2DL1, inhibitory combinations. The “rheostat model” predicts weaker licensing by HLA‐C1/KIR2DL3 interactions than HLA‐C2/KIR2DL1. We analyzed degranulation in NKC subsets expressing single and multiple receptors for HLA‐I. NKG2A had the strongest licensing impact, while KIR2DL3, KIR2DL1, and KIR3DL1 were weaker, and not significantly different to each other. Presence of one or two matched HLA‐C allotypes did not alter licensing of KIR2DL3+ and KIR2DL1+ NKC. Coexpression of activating KIR2DS1 disarmed KIR2DL3+ and KIR2DL1+ NKC to a similar extent. KIR3DL1 and NKG2A combined for more enhanced licensing of double‐positive NKC than the combination of KIR2DL3 and KIR2DL1. Thus, KIR2DL3 and KIR2DL1 have similar capacity to license NKC, suggesting that inhibitory signal strength and amount of available HLA‐C ligands do not correlate with NKC licensing. Altogether, our results show that the basis for disease associations of HLA‐C and KIR2DL likely encompasses factors other than licensing.

[1]  M. Purbhoo,et al.  Peptide selectivity discriminates NK cells from KIR2DL2‐ and KIR2DL3‐positive individuals , 2014, European journal of immunology.

[2]  Jakob Michaëlsson,et al.  Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation , 2014, European journal of immunology.

[3]  Gary E. Swan,et al.  Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry , 2013, Science Translational Medicine.

[4]  Sumati Rajagopalan,et al.  Controlling natural killer cell responses: integration of signals for activation and inhibition. , 2013, Annual review of immunology.

[5]  P. Parham,et al.  Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution , 2013, Nature Reviews Immunology.

[6]  A. Buser,et al.  Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells , 2012, Immunogenetics.

[7]  P. Parham,et al.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[8]  R. Welsh,et al.  Natural killer cells act as rheostats modulating antiviral T cells , 2011, Nature.

[9]  P. J. Norris,et al.  Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection , 2011, Proceedings of the National Academy of Sciences.

[10]  E. Adams,et al.  Coevolution of Killer Cell Ig-Like Receptors with HLA-C To Become the Major Variable Regulators of Human NK Cells , 2010, The Journal of Immunology.

[11]  D. Raulet,et al.  Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment , 2010, The Journal of experimental medicine.

[12]  Eric O Long,et al.  Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. , 2010, Immunity.

[13]  H. Ljunggren,et al.  Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. , 2010, Blood.

[14]  Derek Middleton,et al.  The extensive polymorphism of KIR genes , 2010, Immunology.

[15]  É. Vivier,et al.  NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model 1 , 2009, The Journal of Immunology.

[16]  P. Brodin,et al.  NK cell education: not an on-off switch but a tunable rheostat. , 2009, Trends in immunology.

[17]  Sofia Johansson,et al.  The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. , 2009, Blood.

[18]  H. Ljunggren,et al.  Estimation of the Size of the Alloreactive NK Cell Repertoire: Studies in Individuals Homozygous for the Group A KIR Haplotype1 , 2008, The Journal of Immunology.

[19]  Peter Parham,et al.  MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. , 2008, Blood.

[20]  D. Raulet,et al.  Regulation of NK cell responsiveness to achieve self‐tolerance and maximal responses to diseased target cells , 2008, Immunological reviews.

[21]  Eric O Long.  Negative signaling by inhibitory receptors: the NK cell paradigm , 2008, Immunological reviews.

[22]  P. Parham,et al.  Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL31 , 2008, The Journal of Immunology.

[23]  J. Piccirillo,et al.  HLA alleles determine differences in human natural killer cell responsiveness and potency , 2008, Proceedings of the National Academy of Sciences.

[24]  J. Chewning,et al.  Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands , 2007, The Journal of Immunology.

[25]  D. Altmann,et al.  Natural killer cells, killer immunoglobulin‐like receptors and human leucocyte antigen class I in disease , 2007, Clinical and experimental immunology.

[26]  Mary Carrington,et al.  KIR and disease: a model system or system of models? , 2006, Immunological reviews.

[27]  D. Middleton,et al.  Human NK cell education by inhibitory receptors for MHC class I. , 2006, Immunity.

[28]  Y. Lacasse,et al.  From the authors , 2005, European Respiratory Journal.

[29]  L. Lybarger,et al.  Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.

[30]  Sumati Rajagopalan,et al.  Understanding how combinations of HLA and KIR genes influence disease , 2005, The Journal of experimental medicine.

[31]  P. Parham.  MHC class I molecules and kirs in human history, health and survival , 2005, Nature Reviews Immunology.

[32]  Salim I. Khakoo,et al.  HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.

[33]  Eric O Long,et al.  Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. , 1998, Journal of immunology.

[34]  P. Parham,et al.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor , 1995, The Journal of experimental medicine.

[35]  G. Ferrara,et al.  HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Ciccone,et al.  P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities , 1993, The Journal of experimental medicine.

[37]  Annette Oxenius,et al.  NK cells regulating T cell responses: mechanisms and outcome. , 2015, Trends in immunology.

[38]  Eric O Long,et al.  Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. , 2006, Blood.

[39]  Eric O Long,et al.  Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. , 1996, Immunity.